A large global pharmaceutical company wanted to better understand the product potential of a HER3 directed ADC for the treatment of patients with metastatic NSCLC
Viscadia was tasked with designing and building custom forecast platforms and processes catering to the U.S., EU5, Japan, and China to support cross-functional stakeholder objectives leading up to its launch
Conducted in-depth interviews with global and regional stakeholders.
Audited literature and deep dived into existing forecast models
Designed patient segments to account for patient’s treatment choice in each line of therapy
Aligned treatment eligibility and patient opportunity segments
Collaborated with stakeholders to incorporate regional nuances into the forecast model flow
Devised developed a comprehensive forecasting framework that could scale across regions
Designed market share modeling framework by calibrating inputs from the physician research
Modeled event impact due to competitor launches at the segment level
Design and built patient flow forecast models for each region
Built a global forecast model aggregator for the headquarters to assimilate forecasts from different regions
Designed clear, comprehensive and actionable forecast summaries for executive decision making
Automated the workflow of consolidating regional forecast scenarios into a single storybaord
© 2025 Viscadia Inc. All Rights Reserved. Privacy Policy Terms of Use